Welcome to LookChem.com Sign In|Join Free

CAS

  • or

497946-53-9

Post Buying Request

497946-53-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

497946-53-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 497946-53-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,7,9,4 and 6 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 497946-53:
(8*4)+(7*9)+(6*7)+(5*9)+(4*4)+(3*6)+(2*5)+(1*3)=229
229 % 10 = 9
So 497946-53-9 is a valid CAS Registry Number.

497946-53-9Relevant articles and documents

Microwave promoted one-pot synthesis of 2-aryl substituted 1,3,4-oxadiazoles and 1,2,4-oxadiazole derivatives using Al3+-K10 clay as a heterogeneous catalyst

Suresh, Dhanusu,Kanagaraj, Kuppusamy,Pitchumani, Kasi

supporting information, p. 3678 - 3682 (2014/06/23)

An efficient, inexpensive method is developed for the one-pot synthesis of 2-aryl substituted 1,3,4-oxadiazoles and 1,2,4-oxadiazoles starting from acid hydrazides and trimethyl orthoformate under solvent-free, microwave conditions using a reusable Alsup

P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K

Barrett, David G.,Boncek, Virginia M.,Catalano, John G.,Deaton, David N.,Hassell, Anne M.,Jurgensen, Cynthia H.,Long, Stacey T.,McFadyen, Robert B.,Miller, Aaron B.,Miller, Larry R.,Payne, J. Alan,Ray, John A.,Samano, Vicente,Shewchuk, Lisa M.,Tavares, Francis X.,Wells-Knecht, Kevin J.,Willard Jr., Derril H.,Wright, Lois L.,Zhou, Hui-Qiang Q.

, p. 3540 - 3546 (2007/10/03)

An orally bioavailable series of ketoamide-based cathepsin K inhibitors with good pharmacokinetic properties has been identified. Starting from a potent inhibitor endowed with poor drug properties, conformational constraint of the P2-P3 linker and modifications to P1′ elements led to an enhancement in potency, solubility, clearance, and bioavailability. These optimized inhibitors attenuated bone resorption in a rat TPTX hypocalcemic bone resorption model.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 497946-53-9